Literature DB >> 28172817

Functional characterization of a chr13q22.1 pancreatic cancer risk locus reveals long-range interaction and allele-specific effects on DIS3 expression.

Jason W Hoskins1, Abdisamad Ibrahim1, Mickey A Emmanuel1, Sarah M Manmiller1, Yinglun Wu1, Maura O'Neill2, Jinping Jia1, Irene Collins1, Mingfeng Zhang1, Janelle V Thomas1, Lauren M Rost1, Sudipto Das2, Hemang Parikh1,3, Jefferson M Haake4, Gail L Matters5, Robert C Kurtz6, William R Bamlet7, Alison Klein8,9, Rachael Stolzenberg-Solomon10, Brian M Wolpin11, Ronit Yarden4, Zhaoming Wang10,12, Jill Smith13, Sara H Olson3, Thorkell Andresson2, Gloria M Petersen7, Laufey T Amundadottir1.   

Abstract

Genome-wide association studies (GWAS) have identified multiple common susceptibility loci for pancreatic cancer. Here we report fine-mapping and functional analysis of one such locus residing in a 610 kb gene desert on chr13q22.1 (marked by rs9543325). The closest candidate genes, KLF5, KLF12, PIBF1, DIS3 and BORA, range in distance from 265-586 kb. Sequencing three sub-regions containing the top ranked SNPs by imputation P-value revealed a 30 bp insertion/deletion (indel) variant that was significantly associated with pancreatic cancer risk (rs386772267, P = 2.30 × 10-11, OR = 1.22, 95% CI 1.15-1.28) and highly correlated to rs9543325 (r2 = 0.97 in the 1000 Genomes EUR population). This indel was the most significant cis-eQTL variant in a set of 222 histologically normal pancreatic tissue samples (β = 0.26, P = 0.004), with the insertion (risk-increasing) allele associated with reduced DIS3 expression. DIS3 encodes a catalytic subunit of the nuclear RNA exosome complex that mediates RNA processing and decay, and is mutated in several cancers. Chromosome conformation capture revealed a long range (570 kb) physical interaction between a sub-region of the risk locus, containing rs386772267, and a region ∼6 kb upstream of DIS3 Finally, repressor regulatory activity and allele-specific protein binding by transcription factors of the TCF/LEF family were observed for the risk-increasing allele of rs386772267, indicating that expression regulation at this risk locus may be influenced by the Wnt signaling pathway. In conclusion, we have identified a putative functional indel variant at chr13q22.1 that associates with decreased DIS3 expression in carriers of pancreatic cancer risk-increasing alleles, and could therefore affect nuclear RNA processing and/or decay. Published by Oxford University Press 2016. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28172817      PMCID: PMC5815622          DOI: 10.1093/hmg/ddw300

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  55 in total

1.  Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility.

Authors:  Dewi Astuti; Mark R Morris; Wendy N Cooper; Raymond H J Staals; Naomi C Wake; Graham A Fews; Harmeet Gill; Dean Gentle; Salwati Shuib; Christopher J Ricketts; Trevor Cole; Anthonie J van Essen; Richard A van Lingen; Giovanni Neri; John M Opitz; Patrick Rump; Irene Stolte-Dijkstra; Ferenc Müller; Ger J M Pruijn; Farida Latif; Eamonn R Maher
Journal:  Nat Genet       Date:  2012-02-05       Impact factor: 38.330

2.  A common variant associated with prostate cancer in European and African populations.

Authors:  Laufey T Amundadottir; Patrick Sulem; Julius Gudmundsson; Agnar Helgason; Adam Baker; Bjarni A Agnarsson; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Jean-Baptiste Cazier; Jesus Sainz; Margret Jakobsdottir; Jelena Kostic; Droplaug N Magnusdottir; Shyamali Ghosh; Kari Agnarsson; Birgitta Birgisdottir; Louise Le Roux; Adalheidur Olafsdottir; Thorarinn Blondal; Margret Andresdottir; Olafia Svandis Gretarsdottir; Jon T Bergthorsson; Daniel Gudbjartsson; Arnaldur Gylfason; Gudmar Thorleifsson; Andrei Manolescu; Kristleifur Kristjansson; Gudmundur Geirsson; Helgi Isaksson; Julie Douglas; Jan-Erik Johansson; Katarina Bälter; Fredrik Wiklund; James E Montie; Xiaoying Yu; Brian K Suarez; Carole Ober; Kathleen A Cooney; Henrik Gronberg; William J Catalona; Gudmundur V Einarsson; Rosa B Barkardottir; Jeffrey R Gulcher; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2006-05-07       Impact factor: 38.330

3.  Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men.

Authors:  Matthew L Freedman; Christopher A Haiman; Nick Patterson; Gavin J McDonald; Arti Tandon; Alicja Waliszewska; Kathryn Penney; Robert G Steen; Kristin Ardlie; Esther M John; Ingrid Oakley-Girvan; Alice S Whittemore; Kathleen A Cooney; Sue A Ingles; David Altshuler; Brian E Henderson; David Reich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

4.  Quantitative analysis of chromosome conformation capture assays (3C-qPCR).

Authors:  Hélène Hagège; Petra Klous; Caroline Braem; Erik Splinter; Job Dekker; Guy Cathala; Wouter de Laat; Thierry Forné
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

5.  Mapping chromatin interactions by chromosome conformation capture.

Authors:  Adriana Miele; Nele Gheldof; Tomoko M Tabuchi; Josée Dostie; Job Dekker
Journal:  Curr Protoc Mol Biol       Date:  2006-05

6.  A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.

Authors:  Gloria M Petersen; Laufey Amundadottir; Charles S Fuchs; Peter Kraft; Rachael Z Stolzenberg-Solomon; Kevin B Jacobs; Alan A Arslan; H Bas Bueno-de-Mesquita; Steven Gallinger; Myron Gross; Kathy Helzlsouer; Elizabeth A Holly; Eric J Jacobs; Alison P Klein; Andrea LaCroix; Donghui Li; Margaret T Mandelson; Sara H Olson; Harvey A Risch; Wei Zheng; Demetrius Albanes; William R Bamlet; Christine D Berg; Marie-Christine Boutron-Ruault; Julie E Buring; Paige M Bracci; Federico Canzian; Sandra Clipp; Michelle Cotterchio; Mariza de Andrade; Eric J Duell; J Michael Gaziano; Edward L Giovannucci; Michael Goggins; Göran Hallmans; Susan E Hankinson; Manal Hassan; Barbara Howard; David J Hunter; Amy Hutchinson; Mazda Jenab; Rudolf Kaaks; Charles Kooperberg; Vittorio Krogh; Robert C Kurtz; Shannon M Lynch; Robert R McWilliams; Julie B Mendelsohn; Dominique S Michaud; Hemang Parikh; Alpa V Patel; Petra H M Peeters; Aleksandar Rajkovic; Elio Riboli; Laudina Rodriguez; Daniela Seminara; Xiao-Ou Shu; Gilles Thomas; Anne Tjønneland; Geoffrey S Tobias; Dimitrios Trichopoulos; Stephen K Van Den Eeden; Jarmo Virtamo; Jean Wactawski-Wende; Zhaoming Wang; Brian M Wolpin; Herbert Yu; Kai Yu; Anne Zeleniuch-Jacquotte; Joseph F Fraumeni; Robert N Hoover; Patricia Hartge; Stephen J Chanock
Journal:  Nat Genet       Date:  2010-01-24       Impact factor: 38.330

7.  An integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancer.

Authors:  Jinping Jia; Hemang Parikh; Wenming Xiao; Jason W Hoskins; Holger Pflicke; Xuelu Liu; Irene Collins; Weiyin Zhou; Zhaoming Wang; John Powell; Snorri S Thorgeirsson; Udo Rudloff; Gloria M Petersen; Laufey T Amundadottir
Journal:  BMC Med Genomics       Date:  2013-09-22       Impact factor: 3.063

Review 8.  Pancreatic Cancer Genetics.

Authors:  Laufey T Amundadottir
Journal:  Int J Biol Sci       Date:  2016-01-28       Impact factor: 6.580

9.  Transcriptome-wide analysis of exosome targets.

Authors:  Claudia Schneider; Grzegorz Kudla; Wiebke Wlotzka; Alex Tuck; David Tollervey
Journal:  Mol Cell       Date:  2012-09-20       Impact factor: 17.970

10.  Five endometrial cancer risk loci identified through genome-wide association analysis.

Authors:  Timothy Ht Cheng; Deborah J Thompson; Tracy A O'Mara; Jodie N Painter; Dylan M Glubb; Susanne Flach; Annabelle Lewis; Juliet D French; Luke Freeman-Mills; David Church; Maggie Gorman; Lynn Martin; Shirley Hodgson; Penelope M Webb; John Attia; Elizabeth G Holliday; Mark McEvoy; Rodney J Scott; Anjali K Henders; Nicholas G Martin; Grant W Montgomery; Dale R Nyholt; Shahana Ahmed; Catherine S Healey; Mitul Shah; Joe Dennis; Peter A Fasching; Matthias W Beckmann; Alexander Hein; Arif B Ekici; Per Hall; Kamila Czene; Hatef Darabi; Jingmei Li; Thilo Dörk; Matthias Dürst; Peter Hillemanns; Ingo Runnebaum; Frederic Amant; Stefanie Schrauwen; Hui Zhao; Diether Lambrechts; Jeroen Depreeuw; Sean C Dowdy; Ellen L Goode; Brooke L Fridley; Stacey J Winham; Tormund S Njølstad; Helga B Salvesen; Jone Trovik; Henrica Mj Werner; Katie Ashton; Geoffrey Otton; Tony Proietto; Tao Liu; Miriam Mints; Emma Tham; Chibcha Consortium; Mulin Jun Li; Shun H Yip; Junwen Wang; Manjeet K Bolla; Kyriaki Michailidou; Qin Wang; Jonathan P Tyrer; Malcolm Dunlop; Richard Houlston; Claire Palles; John L Hopper; Julian Peto; Anthony J Swerdlow; Barbara Burwinkel; Hermann Brenner; Alfons Meindl; Hiltrud Brauch; Annika Lindblom; Jenny Chang-Claude; Fergus J Couch; Graham G Giles; Vessela N Kristensen; Angela Cox; Julie M Cunningham; Paul D P Pharoah; Alison M Dunning; Stacey L Edwards; Douglas F Easton; Ian Tomlinson; Amanda B Spurdle
Journal:  Nat Genet       Date:  2016-05-02       Impact factor: 38.330

View more
  13 in total

1.  A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer.

Authors:  Ashley Jermusyk; Jun Zhong; Katelyn E Connelly; Naomi Gordon; Sumeth Perera; Ehssan Abdolalizadeh; Tongwu Zhang; Aidan O'Brien; Jason W Hoskins; Irene Collins; Daina Eiser; Chen Yuan; Harvey A Risch; Eric J Jacobs; Donghui Li; Mengmeng Du; Rachael Z Stolzenberg-Solomon; Alison P Klein; Jill P Smith; Brian M Wolpin; Stephen J Chanock; Jianxin Shi; Gloria M Petersen; Christopher J Westlake; Laufey T Amundadottir
Journal:  Am J Hum Genet       Date:  2021-09-23       Impact factor: 11.043

2.  A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer.

Authors:  Jun Zhong; Ashley Jermusyk; Lang Wu; Jason W Hoskins; Irene Collins; Evelina Mocci; Mingfeng Zhang; Lei Song; Charles C Chung; Tongwu Zhang; Wenming Xiao; Demetrius Albanes; Gabriella Andreotti; Alan A Arslan; Ana Babic; William R Bamlet; Laura Beane-Freeman; Sonja Berndt; Ayelet Borgida; Paige M Bracci; Lauren Brais; Paul Brennan; Bas Bueno-de-Mesquita; Julie Buring; Federico Canzian; Erica J Childs; Michelle Cotterchio; Mengmeng Du; Eric J Duell; Charles Fuchs; Steven Gallinger; J Michael Gaziano; Graham G Giles; Edward Giovannucci; Michael Goggins; Gary E Goodman; Phyllis J Goodman; Christopher Haiman; Patricia Hartge; Manal Hasan; Kathy J Helzlsouer; Elizabeth A Holly; Eric A Klein; Manolis Kogevinas; Robert J Kurtz; Loic LeMarchand; Núria Malats; Satu Männistö; Roger Milne; Rachel E Neale; Kimmie Ng; Ofure Obazee; Ann L Oberg; Irene Orlow; Alpa V Patel; Ulrike Peters; Miquel Porta; Nathaniel Rothman; Ghislaine Scelo; Howard D Sesso; Gianluca Severi; Sabina Sieri; Debra Silverman; Malin Sund; Anne Tjønneland; Mark D Thornquist; Geoffrey S Tobias; Antonia Trichopoulou; Stephen K Van Den Eeden; Kala Visvanathan; Jean Wactawski-Wende; Nicolas Wentzensen; Emily White; Herbert Yu; Chen Yuan; Anne Zeleniuch-Jacquotte; Robert Hoover; Kevin Brown; Charles Kooperberg; Harvey A Risch; Eric J Jacobs; Donghui Li; Kai Yu; Xiao-Ou Shu; Stephen J Chanock; Brian M Wolpin; Rachael Z Stolzenberg-Solomon; Nilanjan Chatterjee; Alison P Klein; Jill P Smith; Peter Kraft; Jianxin Shi; Gloria M Petersen; Wei Zheng; Laufey T Amundadottir
Journal:  J Natl Cancer Inst       Date:  2020-10-01       Impact factor: 13.506

Review 3.  Targeting RNA for processing or destruction by the eukaryotic RNA exosome and its cofactors.

Authors:  John C Zinder; Christopher D Lima
Journal:  Genes Dev       Date:  2017-01-15       Impact factor: 11.361

Review 4.  Novel insights into chromosomal conformations in cancer.

Authors:  Ruobing Jia; Peiwei Chai; He Zhang; Xianqun Fan
Journal:  Mol Cancer       Date:  2017-11-17       Impact factor: 27.401

5.  Genetic variants in SLC22A3 contribute to the susceptibility to colorectal cancer.

Authors:  Anjing Ren; Shanwen Sun; Shuwei Li; Tao Chen; Yongqian Shu; Mulong Du; Lingjun Zhu
Journal:  Int J Cancer       Date:  2019-01-03       Impact factor: 7.396

Review 6.  Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine.

Authors:  Gwen Lomberk; Nelson Dusetti; Juan Iovanna; Raul Urrutia
Journal:  Nat Commun       Date:  2019-08-28       Impact factor: 14.919

7.  Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan.

Authors:  Yan-Shen Shan; Li-Tzong Chen; Jin-Shang Wu; Yin-Fan Chang; Chih-Ting Lee; Chih-Hsing Wu; Nai-Jung Chiang; Hsin-En Huang; Chia-Jui Yen; Ying-Jui Chao; Hui-Jen Tsai; Chiung-Yu Chen; Jui-Wen Kang; Chin-Fu Kuo; Chia-Rung Tsai; Ya-Ling Weng; Han-Chien Yang; Hui-Chin Liu; Jeffrey S Chang
Journal:  J Biomed Sci       Date:  2020-05-26       Impact factor: 8.410

8.  Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.

Authors:  Sally N Adebamowo; Adebowale A Adeyemo; Charles N Rotimi; Olayinka Olaniyan; Richard Offiong; Clement A Adebamowo
Journal:  BMC Med Genet       Date:  2020-11-23       Impact factor: 2.103

9.  Identification of RNA-binding protein SNRPA1 for prognosis in prostate cancer.

Authors:  Penghui Yuan; Le Ling; Xintao Gao; Taotao Sun; Jianping Miao; Xianglin Yuan; Jihong Liu; Zhihua Wang; Bo Liu
Journal:  Aging (Albany NY)       Date:  2021-01-15       Impact factor: 5.682

10.  Whole-exome analysis in osteosarcoma to identify a personalized therapy.

Authors:  Chiara M Mazzanti; Claudio Di Cristofano; Caterina Chiappetta; Massimiliano Mancini; Francesca Lessi; Paolo Aretini; Veronica De Gregorio; Chiara Puggioni; Raffaella Carletti; Vincenzo Petrozza; Prospero Civita; Sara Franceschi; Antonio G Naccarato; Carlo Della Rocca
Journal:  Oncotarget       Date:  2017-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.